Clinical Trials Directory

Trials / Completed

CompletedNCT04780074

Comparative Single-dose Bioavailability Study of Different CoQ10 Formulations

Comparative Single-dose Bioavailability Study of Different CoQ10 Formulations in Healthy Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Institute of Nutrition, Slovenia (Nutris) · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The single-center, randomized, open-label, five-period crossover single-dose bioavailability study with five CoQ10 formulations

Detailed description

The single-center, randomized, open-label, five-period crossover bioavailability study will include 30 subjects who will test five CoQ10 formulations. Study will be conducted with single dose CoQ10 to assess bioavailability.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTSingle dose intervention with Standard product (SP)2 capsules - 200 mg total CoQ10
DIETARY_SUPPLEMENTSingle dose intervention with Investigational product (IP1)2 softgels - 200 mg total CoQ10
DIETARY_SUPPLEMENTSingle dose intervention with Investigational product (IP2)2 softgels - 200 mg total CoQ10
DIETARY_SUPPLEMENTSingle dose intervention with Investigational product (IP3)2 softgels - 200 mg total CoQ10
DIETARY_SUPPLEMENTSingle dose intervention with Investigational product (IP4)2 capsules - 200 mg total CoQ10

Timeline

Start date
2021-02-28
Primary completion
2021-05-21
Completion
2022-12-13
First posted
2021-03-03
Last updated
2022-12-14

Locations

1 site across 1 country: Slovenia

Source: ClinicalTrials.gov record NCT04780074. Inclusion in this directory is not an endorsement.